Måndag 6 April | 11:26:14 Europe / Stockholm
2025-04-30 11:00:00

Klaria Pharma Holding AB Annual Report 2024

The year in brief

Net sales amounted to 2.2 MSEK (8.5 MSEK)

Other operating income amounted to 0.1 MSEK (0.5 MSEK)

R&D costs amounted to 22.1 MSEK (25.0 MSEK)

Profit/loss after tax amounted to -47.8 MSEK (-35.8 MSEK)

Earnings per share amounted to -0.38 SEK (-0.36 SEK)

Cash flow from operations amounted to -11.9 MSEK (-9.1 MSEK)

Shareholder's equity as of December 31, 2024 amounted to 3.3 MSEK (41.1 MSEK)

Cash and cash equivalents as of December 31, 2024 amounted to 0.6 MSEK (1.2 MSEK)